ARCHIVES

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

House subcommittee’s 5.6% Increase For NIH includes $2.5 Billion for NCI

July 18, 1997

Bush Asks Hammer To Probe FDA Regulation Of Anticancer Drugs

June 17, 1988

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008

Wilex, Fox Chase, Begin Trial Of WX-UK1 Targeting Invasion

May 28, 2004

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998

Oxaliplatin Regimens Extend Survival Of Advanced Colorectal Cancer, Study Finds

June 27, 2003